Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM44V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,655
Award facts
- Contract value 100% obligated
- $63,654.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $63,654.75 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical vendor within the federal pharmaceutical supply chain, distributing a comprehensive range of medications, vaccines, and medical devices across multiple therapeutic domains to military treatment facilities and other federal healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill competitive procurement requirements for specialized pharmaceutical products on an open basis, with delivery orders typically structured as firm fixed-price arrangements. This particular delivery order for Otezla, a specialty medication used in treating autoimmune and inflammatory conditions, reflects the company's ongoing role in supporting military medical readiness and veteran healthcare needs through the DLA's medical supply infrastructure.
Quick answers
Who was awarded contract SPE2DR26FM44V?
SPE2DR26FM44V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FM44V worth?
The government has obligated $63,655 on SPE2DR26FM44V.
Is contract SPE2DR26FM44V an order under another contract?
Yes. SPE2DR26FM44V is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM44V competed?
The extent of competition for SPE2DR26FM44V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award